Tidemark, LLC Immuneering Corp Transaction History
Tidemark, LLC
- $253 Million
- Q4 2024
A detailed history of Tidemark, LLC transactions in Immuneering Corp stock. As of the latest transaction made, Tidemark, LLC holds 44,400 shares of IMRX stock, worth $84,360. This represents 0.04% of its overall portfolio holdings.
Number of Shares
44,400
Previous 51,850
14.37%
Holding current value
$84,360
Previous $129,000
24.81%
% of portfolio
0.04%
Previous 0.05%
Shares
2 transactions
Others Institutions Holding IMRX
# of Institutions
43Shares Held
4.66MCall Options Held
0Put Options Held
0-
Vanguard Group Inc Valley Forge, PA1.07MShares$2.03 Million0.0% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD810KShares$1.54 Million0.0% of portfolio
-
Black Rock Inc. New York, NY533KShares$1.01 Million0.0% of portfolio
-
Morgan Stanley New York, NY449KShares$853,6900.0% of portfolio
-
Israel Englander Millennium Management LLC | New York, Ny246KShares$467,9130.0% of portfolio
About Immuneering Corp
- Ticker IMRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,392,300
- Market Cap $50.1M
- Description
- Immuneering Corporation, a biopharmaceutical company, focuses on the oncology and neuroscience product candidates. Its lead product candidates include IMM-1-104, a dual-MEK inhibitor to treat patients with cancer, including pancreatic, melanoma, colorectal, and non-small cell lung cancer caused by mutations of RAS and/or RAF; and IMM-6-415 to tr...